Press Releases

WASHINGTON, DC – U.S. Congressman Pete Sessions (R-TX-32), Chairman of the House Rules Committee, secured approval of his amendment with Congressman Mike Thompson (D-CA-01) to expedite innovative treatments to active duty soldiers suffering from Traumatic Brain Injuries (TBI) and Post-Traumatic Stress Disorder (PTSD). Originally introduced by Sessions as the TBI Treatment Act (H.R. 2344), his TBI treatment expansion proposal was adopted as an amendment the National Defense Authorization Act (NDAA) for Fiscal Year 2014 in June and the Department of Defense Appropriations Act for Fiscal Year 2014 this week.

“I’m pleased that my colleagues in the House have once again joined me in supporting our nation’s soldiers who return from combat suffering from TBI and PTSD,” said Sessions. “These brave men and women have sacrificed for our country and we have a solemn duty to ensure that they have access to leading-edge treatments.”

Sessions’ initiative creates a five-year pilot program that allows military patients to receive care from private physicians who provide treatment options not currently available within military medical facilities.  Physicians may qualify for payment from the Department of Defense through a “pay-for-performance” plan, meaning that they must prove that a patient has experienced demonstrable improvement in order to get paid. Safeguards ensure that our wounded warriors have access to safe and innovative private treatments while reserving payment only for treatments that have been proven to work.

“Our nation’s brave service men and women deserve nothing less than to receive the highest quality health care in America,” added Sessions. “That is why I will continue to fight to provide them with the most effective treatments available, whether through government or private health care.”


Washington, D.C. Office

2233 Rayburn House Office Building
Washington, DC 20515-4332
P: (202) 225-2231
F: (202) 225-5878

Dallas, TX Office

Park Central VII
12750 Merit Drive, Suite 1434
Dallas, Texas 75251-1229
P: (972) 392-0505
F: (972) 392-0615

Contact Me